How to use this comparison
Use this page to prepare questions before a myopia consultation. It cannot replace a personalised eye examination.
Ashfield NSW local optometrist
Atropine and MiyoSmart are different management pathways. Atropine involves medication and may require prescribing pathways, while MiyoSmart is a spectacle lens option.
Compare atropine discussion pathways and MiyoSmart spectacle lenses for children's myopia control.
Reviewed by: Dr. Shirley Wang, B.Optom UNSW
Qualifications: Bachelor of Optometry, University of New South Wales
Languages: English, Mandarin Chinese, Cantonese Chinese
Last medically reviewed: July 2026
| Topic | Comparison | Parent question |
|---|---|---|
| Treatment type | Atropine is an eye drop pathway; MiyoSmart is a spectacle lens option. | Ask what is suitable for your child's age, risk and eye health. |
| Compliance | Atropine depends on drop use; MiyoSmart depends on wearing glasses. | Choose a plan the family can follow. |
| Side effects and practicalities | Atropine may involve light sensitivity or near blur depending on dose. | Discuss risks, benefits and review timing with the optometrist. |
Use this page to prepare questions before a myopia consultation. It cannot replace a personalised eye examination.
The optometrist considers age, prescription, progression history, eye health, family preferences, language needs, lifestyle and review commitment.
Book a children's vision or myopia-control appointment if your child's prescription is changing, they struggle to see the board, or you want to compare options.
There is no single best option for every child. Suitability depends on prescription, eye health, maturity, habits and family needs.
Yes. Dr Shirley Wang can discuss suitable myopia-control options at iFocus Optometrists Ashfield.
Yes. Previous prescriptions help the optometrist understand progression history.